VistaGen Therapeutics, Inc. (VTGN) SEC filings
VTGN SEC filings moved a median of +0.32% by the close. VTGN SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the VTGN overview →
82 measured VTGN SEC filing events.
Where these VTGN SEC filings landedvs 80 measured VTGN SEC filing reactions
| Middle 50% of VTGN SEC filing reactions | -2.90% to +3.39% |
|---|---|
| Median reaction (to close) | +0.32% |
| Measured reactions | 80 |
Point-in-time · zero look-ahead
Half of the 80 VTGN SEC filing events with a measured close landed between -2.90% and +3.39%; 57% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Vistagen Therapeutics, For: Oct 07 | SEC filing · Form 8-K | -1.14% | -3.98% | |
| Form 8-K Vistagen Therapeutics, For: Sep 25 | SEC filing · Form 8-K | +0.52% | -3.81% | |
| Form 8-K Vistagen Therapeutics, For: Sep 24 | SEC filing · Form 8-K | -4.58% | -15.47% | |
| Form 8-K Vistagen Therapeutics, For: Sep 22 | SEC filing · Form 8-K | +6.76% | -4.58% | |
| Form 8-K Vistagen Therapeutics, For: Sep 10 | SEC filing · Form 8-K | -1.29% | -1.21% | |
| Form 10-Q Vistagen Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -2.19% | -3.70% | |
| Form 8-K Vistagen Therapeutics, For: Aug 14 | SEC filing · Form 8-K | -1.63% | -0.89% | |
| Form 8-K Vistagen Therapeutics, For: Aug 06 | SEC filing · Form 8-K | -1.78% | +0.14% | |
| Form 8-K Vistagen Therapeutics, For: Aug 04 | SEC filing · Form 8-K | +0.03% | -4.44% | |
| Form 8-K Vistagen Therapeutics, For: Jul 29 | SEC filing · Form 8-K | -1.07% | -1.15% | |
| Form DEF 14A Vistagen Therapeutics, For: Jul 31 | SEC filing · Form DEF | -3.16% | -2.00% | |
| Form DEFA14A Vistagen Therapeutics, | SEC filing · Form DEFA14A | -3.16% | -2.00% | |
| Form 8-K Vistagen Therapeutics, For: Jun 30 | SEC filing · Form 8-K | +0.91% | +7.62% | |
| Form 8-K Vistagen Therapeutics, For: Jun 16 | SEC filing · Form 8-K | +4.03% | -3.15% | |
| Form 10-K Vistagen Therapeutics, For: Mar 31 | SEC filing · Form 10-K | -3.43% | +18.97% | |
| Form 8-K Vistagen Therapeutics, For: Jun 15 | SEC filing · Form 8-K | -3.43% | +18.97% | |
| Form 8-K Vistagen Therapeutics, For: Jun 09 | SEC filing · Form 8-K | -0.83% | -0.91% | |
| Form 8-K Vistagen Therapeutics, For: May 18 | SEC filing · Form 8-K | -1.97% | +1.56% | |
| Form 8-K Vistagen Therapeutics, For: May 12 | SEC filing · Form 8-K | -5.34% | +0.02% | |
| Form 8-K Vistagen Therapeutics, For: May 08 | SEC filing · Form 8-K | +0.43% | +10.43% | |
| Form 8-K Vistagen Therapeutics, For: Apr 22 | SEC filing · Form 8-K | -1.34% | +1.34% | |
| Form 8-K Vistagen Therapeutics, For: Apr 07 | SEC filing · Form 8-K | +2.12% | +1.70% | |
| Form 8-K Vistagen Therapeutics, For: Apr 01 | SEC filing · Form 8-K | -1.25% | -6.01% | |
| Form 8-K Vistagen Therapeutics, For: Mar 17 | SEC filing · Form 8-K | +0.00% | +7.05% | |
| Form 8-K Vistagen Therapeutics, For: Mar 16 | SEC filing · Form 8-K | -1.22% | +2.57% | |
| Form 8-K Vistagen Therapeutics, For: Mar 05 | SEC filing · Form 8-K | +9.34% | +7.29% | |
| Form 8-K Vistagen Therapeutics, For: Feb 13 | SEC filing · Form 8-K | -3.37% | -5.22% | |
| Form 10-Q Vistagen Therapeutics, For: Dec 31 | SEC filing · Form 10-Q | -8.38% | +5.33% | |
| Form 8-K Vistagen Therapeutics, For: Feb 12 | SEC filing · Form 8-K | -8.38% | +5.33% | |
| Form 8-K Vistagen Therapeutics, For: Feb 03 | SEC filing · Form 8-K | +0.36% | +5.75% | |
| Form 8-K Vistagen Therapeutics, For: Jan 09 | SEC filing · Form 8-K | -2.19% | +4.28% | |
| Form 8-K Vistagen Therapeutics, For: Dec 17 | SEC filing · Form 8-K | -2.23% | -4.92% | |
| Form 8-K Vistagen Therapeutics, For: Nov 28 | SEC filing · Form 8-K | +0.80% | +14.44% | |
| Form 8-K Vistagen Therapeutics, For: Nov 03 | SEC filing · Form 8-K | -0.36% | +0.72% | |
| Form 8-K Vistagen Therapeutics, For: Oct 27 | SEC filing · Form 8-K | -0.25% | -5.30% | |
| Form 8-K Vistagen Therapeutics, For: Sep 09 | SEC filing · Form 8-K | -1.27% | -7.91% | |
| Form 10-Q Vistagen Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.72% | +7.22% | |
| Form 8-K Vistagen Therapeutics, For: Aug 07 | SEC filing · Form 8-K | -0.72% | +7.22% | |
| Form DEF 14A Vistagen Therapeutics, For: Sep 09 | SEC filing · Form DEF | +1.57% | — | |
| Form DEFA14A Vistagen Therapeutics, | SEC filing · Form DEFA14A | +1.57% | — | |
| Form 8-K Vistagen Therapeutics, For: Jun 23 | SEC filing · Form 8-K | -2.45% | +0.49% | |
| Form 10-K Vistagen Therapeutics, For: Mar 31 | SEC filing · Form 10-K | -3.88% | -11.21% | |
| Form 8-K Vistagen Therapeutics, For: Jun 17 | SEC filing · Form 8-K | -3.88% | -11.21% | |
| Form 8-K Vistagen Therapeutics, For: Jun 02 | SEC filing · Form 8-K | -1.70% | -0.83% | |
| Form 8-K Vistagen Therapeutics, For: Mar 03 | SEC filing · Form 8-K | -0.38% | +3.37% | |
| Form 10-Q Vistagen Therapeutics, For: Dec 31 | SEC filing · Form 10-Q | -2.71% | +0.68% | |
| Form 8-K Vistagen Therapeutics, For: Feb 13 | SEC filing · Form 8-K | -2.71% | +0.68% | |
| Form 8-K Vistagen Therapeutics, For: Feb 05 | SEC filing · Form 8-K | +0.00% | -4.33% | |
| Form 8-K Vistagen Therapeutics, For: Jan 14 | SEC filing · Form 8-K | +0.69% | +2.06% | |
| Form 8-K Vistagen Therapeutics, For: Jan 10 | SEC filing · Form 8-K | -2.05% | -3.07% | |
| Form 8-K Vistagen Therapeutics, For: Dec 06 | SEC filing · Form 8-K | +1.06% | +0.00% | |
| Form 10-Q Vistagen Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.38% | +0.32% | |
| Form 8-K Vistagen Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +1.38% | +0.32% | |
| Form 8-K Vistagen Therapeutics, For: Sep 23 | SEC filing · Form 8-K | +2.36% | -4.42% | |
| Form 8-K Vistagen Therapeutics, For: Aug 26 | SEC filing · Form 8-K | +1.10% | -0.28% | |
| Form 10-Q Vistagen Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +2.50% | |
| Form 8-K Vistagen Therapeutics, For: Aug 13 | SEC filing · Form 8-K | +0.00% | +2.50% | |
| Form DEF 14A Vistagen Therapeutics, For: Aug 26 | SEC filing · Form DEF | +0.27% | +3.22% | |
| Form DEFA14A Vistagen Therapeutics, | SEC filing · Form DEFA14A | +0.27% | +3.22% | |
| Form 8-K Vistagen Therapeutics, For: Jul 08 | SEC filing · Form 8-K | +1.01% | +0.26% | |
| Form 8-K Vistagen Therapeutics, For: Jul 09 | SEC filing · Form 8-K | +1.27% | +10.77% | |
| Form 8-K Vistagen Therapeutics, For: Jun 27 | SEC filing · Form 8-K | +0.00% | +2.29% | |
| Form S-8 Vistagen Therapeutics, | SEC filing · Form S-8 | +0.17% | -0.87% | |
| Form 10-K Vistagen Therapeutics, For: Mar 31 | SEC filing · Form 10-K | +1.32% | -2.90% | |
| Form 8-K Vistagen Therapeutics, For: Jun 11 | SEC filing · Form 8-K | +1.32% | -2.90% | |
| Form 8-K Vistagen Therapeutics, For: May 29 | SEC filing · Form 8-K | -0.26% | +0.26% | |
| Form 8-K Vistagen Therapeutics, For: May 23 | SEC filing · Form 8-K | -0.73% | -0.49% | |
| Form 8-K Vistagen Therapeutics, For: Apr 25 | SEC filing · Form 8-K | -0.64% | +0.85% | |
| Form DEF 14A Vistagen Therapeutics, For: May 29 | SEC filing · Form DEF | -0.22% | +0.22% | |
| Form PRE 14A Vistagen Therapeutics, For: May 29 | SEC filing · Form PRE | -0.89% | +1.77% | |
| Form 8-K Vistagen Therapeutics, For: Apr 01 | SEC filing · Form 8-K | -2.68% | +3.45% | |
| Form EFFECT Vistagen Therapeutics, | SEC filing · Form EFFECT | -0.39% | -0.98% | |
| Form 10-Q Vistagen Therapeutics, For: Dec 31 | SEC filing · Form 10-Q | +2.16% | +5.89% | |
| Form 8-K Vistagen Therapeutics, For: Feb 13 | SEC filing · Form 8-K | +2.16% | +5.89% | |
| Form S-3 Vistagen Therapeutics, | SEC filing · Form S-3 | +2.16% | +5.89% | |
| Form 8-K Vistagen Therapeutics, For: Jan 08 | SEC filing · Form 8-K | +0.73% | +5.78% | |
| Form 8-K Vistagen Therapeutics, For: Dec 27 | SEC filing · Form 8-K | +0.72% | +4.52% | |
| Form 10-Q Vistagen Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.04% | -10.76% | |
| Form 8-K Vistagen Therapeutics, For: Nov 09 | SEC filing · Form 8-K | -1.04% | -10.76% | |
| Form 8-K/A Vistagen Therapeutics, For: Nov 02 | SEC filing · Form 8-K | -0.89% | +3.12% | |
| Form 8-K Vistagen Therapeutics, For: Nov 02 | SEC filing · Form 8-K | -0.89% | +3.12% | |
| Form 8-K Vistagen Therapeutics, For: Oct 24 | SEC filing · Form 8-K | +1.01% | -1.68% |
Keep exploring
More VTGN: earnings → · analyst actions → · VTGN overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Gritstone bio, Inc. (GRTS) | 659 | -0.01% | 50% |
| Inovio Pharmaceuticals, Inc. (INO) | 658 | -0.29% | 43% |
| Quanterix Corporation (QTRX) | 657 | -0.21% | 46% |
| Encompass Health Corporation (EHC) | 656 | +0.01% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.